Susquehanna International Group’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-110,200
| Closed | -$644K | – | 14051 |
|
|
2025
Q1 | $644K | Buy |
+110,200
| New | +$581K | ﹤0.01% | 8346 |
|
|
2024
Q4 | – | Sell |
-13,600
| Closed | -$76K | – | 13489 |
|
|
2024
Q3 | $76K | Buy |
13,600
+100
| +0.7% | +$700 | ﹤0.01% | 11196 |
|
|
2024
Q2 | $114K | Sell |
13,500
-12,900
| -49% | -$138K | ﹤0.01% | 10925 |
|
|
2024
Q1 | $381K | Sell |
26,400
-60,300
| -70% | -$997K | ﹤0.01% | 9138 |
|
|
2023
Q4 | $1.87M | Buy |
86,700
+55,000
| +174% | +$981K | ﹤0.01% | 5511 |
|
|
2023
Q3 | $609K | Buy |
31,700
+9,400
| +42% | +$200K | ﹤0.01% | 7764 |
|
|
2023
Q2 | $567K | Sell |
22,300
-14,200
| -39% | -$410K | ﹤0.01% | 8019 |
|
|
2023
Q1 | $1.32M | Sell |
36,500
-3,000
| -8% | -$105K | ﹤0.01% | 6119 |
|
|
2022
Q4 | $1.56M | Sell |
39,500
-40,700
| -51% | -$1.69M | ﹤0.01% | 5191 |
|
|
2022
Q3 | $3.74M | Buy |
80,200
+19,300
| +32% | +$896K | ﹤0.01% | 3654 |
|
|
2022
Q2 | $2.67M | Sell |
60,900
-13,200
| -18% | -$726K | ﹤0.01% | 4290 |
|
|
2022
Q1 | $5.36M | Buy |
74,100
+35,100
| +90% | +$2.53M | ﹤0.01% | 3523 |
|
|
2021
Q4 | $3.16M | Buy |
39,000
+11,200
| +40% | +$1.12M | ﹤0.01% | 4556 |
|
|
2021
Q3 | $3.23M | Buy |
27,800
+6,700
| +32% | +$877K | ﹤0.01% | 4795 |
|
|
2021
Q2 | $3.5M | Buy |
21,100
+3,500
| +20% | +$546K | ﹤0.01% | 4708 |
|
|
2021
Q1 | $2.46M | Sell |
17,600
-15,900
| -47% | -$2.59M | ﹤0.01% | 5416 |
|
|
2020
Q4 | $5.8M | Sell |
33,500
-39,800
| -54% | -$6.45M | ﹤0.01% | 3201 |
|
|
2020
Q3 | $10.2M | Sell |
73,300
-25,300
| -26% | -$3.38M | ﹤0.01% | 2143 |
|
|
2020
Q2 | $11.8M | Sell |
98,600
-73,700
| -43% | -$8.74M | ﹤0.01% | 1951 |
|
|
2020
Q1 | $17.2M | Buy |
172,300
+71,500
| +71% | +$8.6M | 0.01% | 1285 |
|
|
2019
Q4 | $11.8M | Buy |
100,800
+62,300
| +162% | +$6.17M | ﹤0.01% | 1900 |
|
|
2019
Q3 | $3.31M | Buy |
38,500
+500
| +1% | +$37.8K | ﹤0.01% | 3335 |
|
|
2019
Q2 | $2.46M | Sell |
38,000
-112,400
| -75% | -$7M | ﹤0.01% | 3769 |
|
|
2019
Q1 | $9.4M | Sell |
150,400
-185,900
| -55% | -$8.74M | ﹤0.01% | 1794 |
|
|
2018
Q4 | $13.1M | Buy |
336,300
+281,900
| +518% | +$12.5M | 0.01% | 1376 |
|
|
2018
Q3 | $3.1M | Buy |
54,400
+12,500
| +30% | +$781K | ﹤0.01% | 3320 |
|
|
2018
Q2 | $3.35M | Sell |
41,900
-82,400
| -66% | -$6.84M | ﹤0.01% | 3246 |
|
|
2018
Q1 | $10.8M | Buy |
124,300
+40,400
| +48% | +$3.26M | ﹤0.01% | 1712 |
|
|
2017
Q4 | $5.79M | Sell |
83,900
-105,100
| -56% | -$8.41M | ﹤0.01% | 2374 |
|
|
2017
Q3 | $17.2M | Buy |
189,000
+154,900
| +454% | +$13.3M | 0.01% | 1334 |
|
|
2017
Q2 | $2.54M | Sell |
34,100
-53,700
| -61% | -$4.3M | ﹤0.01% | 3457 |
|
|
2017
Q1 | $8.23M | Sell |
87,800
-37,100
| -30% | -$3.36M | ﹤0.01% | 1817 |
|
|
2016
Q4 | $9.07M | Buy |
124,900
+58,300
| +88% | +$4.99M | ﹤0.01% | 1655 |
|
|
2016
Q3 | $6.95M | Sell |
66,600
-76,400
| -53% | -$6.9M | ﹤0.01% | 1868 |
|
|
2016
Q2 | $10.5M | Buy |
143,000
+106,800
| +295% | +$7.25M | 0.01% | 1414 |
|
|
2016
Q1 | $2.04M | Buy |
36,200
+27,100
| +298% | +$1.6M | ﹤0.01% | 3727 |
|
|
2015
Q4 | $614K | Sell |
9,100
-10,200
| -53% | -$546K | ﹤0.01% | 6371 |
|
|
2015
Q3 | $895K | Buy |
19,300
+4,300
| +29% | +$208K | ﹤0.01% | 5993 |
|
|
2015
Q2 | $806K | Buy |
+15,000
| New | +$764K | ﹤0.01% | 6654 |
|
Other funds holding NVRO
Susquehanna International Group's NVRO Position: Q2 2025 in Review
Susquehanna International Group sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 76,479 shares — an estimated $447K sold.
Susquehanna International Group first reported a position in NVRO in Q4 2014 and held it in 30 quarters. The position peaked at $5.19M in Q1 2023. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Susquehanna International Group reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Susquehanna International Group sold 76,479 NEVRO CORP. shares in Q2 2025, an estimated $447K.
- Susquehanna International Group first reported a position in NEVRO CORP. in Q4 2014 and held it in 30 quarters.
- Susquehanna International Group's NEVRO CORP. position peaked at $5.19M in Q1 2023.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.